Matches in Nanopublications for { ?s ?p "[Previously, it was reported that the second ligand-binding domain (LBD II) of megalin is involved in the pathogenesis of passive HN because it is capable of binding antibodies in vivo and initiating formation of immune deposits (ID).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP651236.RA65KSoXu6uId4yG7sc_fcjOLKC5TjCy2PSh5MR69L2aw130_assertion description "[Previously, it was reported that the second ligand-binding domain (LBD II) of megalin is involved in the pathogenesis of passive HN because it is capable of binding antibodies in vivo and initiating formation of immune deposits (ID).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651236.RA65KSoXu6uId4yG7sc_fcjOLKC5TjCy2PSh5MR69L2aw130_provenance.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion description "[Previously, it was reported that the second ligand-binding domain (LBD II) of megalin is involved in the pathogenesis of passive HN because it is capable of binding antibodies in vivo and initiating formation of immune deposits (ID).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_provenance.